$3.47B Market Cap.
RNA Market Cap. (MRY)
RNA Shares Outstanding (MRY)
RNA Assets (MRY)
Total Assets
$1.56B
Total Liabilities
$138.94M
Total Investments
$1.28B
RNA Income (MRY)
Revenue
$10.90M
Net Income
-$322.30M
Operating Expense
$389.83M
RNA Cash Flow (MRY)
CF Operations
-$300.87M
CF Investing
-$854.20M
CF Financing
$1.19B
RNA Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
RNA Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $1,563,895,000 (148.81%) | $628,555,000 (-1.60%) | $638,800,000 (49.40%) | $427,580,000 (28.06%) |
Assets Current | $1,542,290,000 (152.29%) | $611,307,000 (-1.87%) | $622,942,000 (51.52%) | $411,141,000 (23.96%) |
Assets Non-Current | $21,605,000 (25.26%) | $17,248,000 (8.77%) | $15,858,000 (-3.53%) | $16,439,000 (640.50%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $1,424,959,000 (184.56%) | $500,764,000 (-13.37%) | $578,075,000 (51.55%) | $381,430,000 (24.56%) |
Property Plant & Equipment Net | $18,289,000 (9.83%) | $16,652,000 (10.95%) | $15,009,000 (-3.72%) | $15,589,000 (711.08%) |
Cash & Equivalents | $222,663,000 (20.11%) | $185,377,000 (-45.58%) | $340,647,000 (6.22%) | $320,699,000 (-0.32%) |
Accumulated Other Comprehensive Income | $2,902,000 (2221.60%) | $125,000 (104.63%) | -$2,698,000 (-1342.78%) | -$187,000 (-3640.00%) |
Deferred Revenue | $58,948,000 (-14.89%) | $69,263,000 (1003.62%) | $6,276,000 (-44.93%) | $11,396,000 (-28.06%) |
Total Investments | $1,281,629,000 (212.39%) | $410,269,000 (51.77%) | $270,331,000 (217.68%) | $85,095,000 (1174.07%) |
Investments Current | $1,281,629,000 (212.39%) | $410,269,000 (51.77%) | $270,331,000 (217.68%) | $85,095,000 (1174.07%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $69,524,000 (102.45%) | $34,341,000 (5.43%) | $32,572,000 (131.25%) | $14,085,000 (81.86%) |
Accumulated Retained Earnings (Deficit) | -$893,066,000 (-56.47%) | -$570,764,000 (-59.19%) | -$358,544,000 (-94.28%) | -$184,549,000 (-177.35%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $6,801,000 (-30.97%) | $9,852,000 (-7.81%) | $10,687,000 (-8.88%) | $11,729,000 (1150.43%) |
Debt Current | $3,844,000 (5.63%) | $3,639,000 (17.20%) | $3,105,000 (75.52%) | $1,769,000 (0%) |
Debt Non-Current | $2,957,000 (-52.41%) | $6,213,000 (-18.06%) | $7,582,000 (-23.88%) | $9,960,000 (961.83%) |
Total Liabilities | $138,936,000 (8.72%) | $127,791,000 (110.44%) | $60,725,000 (31.58%) | $46,150,000 (66.76%) |
Liabilities Current | $98,018,000 (21.49%) | $80,680,000 (55.43%) | $51,908,000 (75.02%) | $29,658,000 (103.32%) |
Liabilities Non-Current | $40,918,000 (-13.15%) | $47,111,000 (434.32%) | $8,817,000 (-46.54%) | $16,492,000 (26.01%) |
RNA Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $10,897,000 (13.99%) | $9,560,000 (3.64%) | $9,224,000 (-1.09%) | $9,326,000 (37.41%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $86,240,000 (59.14%) | $54,190,000 (43.61%) | $37,733,000 (44.05%) | $26,195,000 (94.58%) |
Research & Development Expense | $303,593,000 (58.98%) | $190,968,000 (26.97%) | $150,404,000 (48.65%) | $101,182,000 (169.09%) |
Operating Expenses | $389,833,000 (59.01%) | $245,158,000 (30.31%) | $188,137,000 (47.70%) | $127,377,000 (149.45%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$322,302,000 (-51.87%) | -$212,220,000 (-21.97%) | -$173,995,000 (-47.44%) | -$118,009,000 (-166.06%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$322,302,000 (-51.87%) | -$212,220,000 (-21.97%) | -$173,995,000 (-47.44%) | -$118,009,000 (-166.06%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$322,302,000 (-51.87%) | -$212,220,000 (-21.97%) | -$173,995,000 (-47.44%) | -$118,009,000 (-166.06%) |
Weighted Average Shares | $111,582,000 (52.83%) | $73,012,000 (39.97%) | $52,162,000 (25.91%) | $41,428,000 (91.24%) |
Weighted Average Shares Diluted | $111,582,000 (52.83%) | $73,012,000 (39.97%) | $52,162,000 (25.91%) | $41,428,000 (91.24%) |
Earning Before Interest & Taxes (EBIT) | -$322,302,000 (-51.87%) | -$212,220,000 (-21.97%) | -$173,995,000 (-47.44%) | -$118,009,000 (-167.32%) |
Gross Profit | $10,897,000 (13.99%) | $9,560,000 (3.64%) | $9,224,000 (-1.09%) | $9,326,000 (37.41%) |
Operating Income | -$378,936,000 (-60.84%) | -$235,598,000 (-31.68%) | -$178,913,000 (-51.56%) | -$118,051,000 (-166.62%) |
RNA Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$854,201,000 (-556.72%) | -$130,070,000 (31.53%) | -$189,955,000 (-130.20%) | -$82,517,000 (-959.95%) |
Net Cash Flow from Financing | $1,192,357,000 (1170.30%) | $93,864,000 (-72.89%) | $346,171,000 (96.34%) | $176,316,000 (-35.19%) |
Net Cash Flow from Operations | -$300,870,000 (-152.70%) | -$119,064,000 (12.63%) | -$136,268,000 (-43.72%) | -$94,813,000 (-155.44%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $37,286,000 (124.01%) | -$155,270,000 (-878.37%) | $19,948,000 (2067.26%) | -$1,014,000 (-100.45%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$847,135,000 (-573.17%) | -$125,842,000 (32.75%) | -$187,132,000 (-137.55%) | -$78,777,000 (-1077.01%) |
Capital Expenditure | -$7,066,000 (-67.12%) | -$4,228,000 (-49.77%) | -$2,823,000 (24.52%) | -$3,740,000 (-242.49%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $1,192,357,000 (1170.30%) | $93,864,000 (-72.89%) | $346,171,000 (96.34%) | $176,316,000 (-35.77%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $51,363,000 (34.38%) | $38,222,000 (40.84%) | $27,139,000 (59.12%) | $17,056,000 (295.73%) |
Depreciation Amortization & Accretion | $6,073,000 (19.57%) | $5,079,000 (266.19%) | $1,387,000 (117.06%) | $639,000 (71.31%) |
RNA Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -2957.70% (-33.24%) | -2219.90% (-17.69%) | -1886.30% (-49.07%) | -1265.40% (-93.63%) |
EBITDA Margin | -2902.00% (-33.94%) | -2166.70% (-15.79%) | -1871.30% (-48.69%) | -1258.50% (-95.12%) |
Return on Average Equity (ROAE) | -25.90% (34.76%) | -39.70% (2.70%) | -40.80% (-14.61%) | -35.60% (-78.00%) |
Return on Average Assets (ROAA) | -23.40% (33.14%) | -35.00% (3.85%) | -36.40% (-12.35%) | -32.40% (-106.37%) |
Return on Sales (ROS) | -2957.70% (-33.24%) | -2219.90% (-17.69%) | -1886.30% (-49.07%) | -1265.40% (-94.56%) |
Return on Invested Capital (ROIC) | -36.40% (27.20%) | -50.00% (24.70%) | -66.40% (89.01%) | -604.00% (-171.77%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -10.06 (-223.54%) | -3.11 (53.19%) | -6.64 (20.34%) | -8.34 (33.01%) |
Price to Sales Ratio (P/S) | 297.77 (330.82%) | 69.12 (-44.92%) | 125.48 (18.84%) | 105.59 (29.63%) |
Price to Book Ratio (P/B) | 2.44 (81.85%) | 1.34 (-35.96%) | 2.09 (-28.46%) | 2.92 (-6.52%) |
Debt to Equity Ratio (D/E) | 0.1 (-61.57%) | 0.26 (142.86%) | 0.1 (-13.22%) | 0.12 (34.44%) |
Earnings Per Share (EPS) | -2.89 (0.69%) | -2.91 (12.87%) | -3.34 (-17.19%) | -2.85 (-39.02%) |
Sales Per Share (SPS) | 0.1 (-25.19%) | 0.13 (-25.99%) | 0.18 (-21.33%) | 0.23 (-28.12%) |
Free Cash Flow Per Share (FCFPS) | -2.76 (-63.41%) | -1.69 (36.67%) | -2.67 (-12.11%) | -2.38 (-34.86%) |
Book Value Per Share (BVPS) | 12.77 (86.19%) | 6.86 (-38.11%) | 11.08 (20.36%) | 9.21 (-34.87%) |
Tangible Assets Book Value Per Share (TABVPS) | 14.02 (62.81%) | 8.61 (-29.70%) | 12.25 (18.65%) | 10.32 (-33.04%) |
Enterprise Value Over EBIT (EV/EBIT) | -10 (-233.33%) | -3 (50.00%) | -6 (0.00%) | -6 (57.14%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -9.82 (-241.54%) | -2.87 (53.89%) | -6.23 (-3.71%) | -6.01 (57.37%) |
Asset Turnover | 0.01 (-50.00%) | 0.02 (-15.79%) | 0.02 (-26.92%) | 0.03 (8.33%) |
Current Ratio | 15.73 (107.67%) | 7.58 (-36.86%) | 12 (-13.43%) | 13.86 (-39.03%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$307,936,000 (-149.76%) | -$123,292,000 (11.36%) | -$139,091,000 (-41.13%) | -$98,553,000 (-157.93%) |
Enterprise Value (EV) | $3,104,133,938 (421.48%) | $595,252,349 (-44.67%) | $1,075,848,274 (52.53%) | $705,356,663 (14.30%) |
Earnings Before Tax (EBT) | -$322,302,000 (-51.87%) | -$212,220,000 (-21.97%) | -$173,995,000 (-47.44%) | -$118,009,000 (-166.06%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$316,229,000 (-52.66%) | -$207,141,000 (-20.01%) | -$172,608,000 (-47.06%) | -$117,370,000 (-168.13%) |
Invested Capital | $1,250,015,000 (235.71%) | $372,350,000 (44.92%) | $256,932,000 (188.84%) | $88,952,000 (6175.96%) |
Working Capital | $1,444,272,000 (172.18%) | $530,627,000 (-7.08%) | $571,034,000 (49.69%) | $381,483,000 (20.31%) |
Tangible Asset Value | $1,563,895,000 (148.81%) | $628,555,000 (-1.60%) | $638,800,000 (49.40%) | $427,580,000 (28.06%) |
Market Capitalization | $3,469,514,938 (417.36%) | $670,616,349 (-44.51%) | $1,208,523,274 (8.41%) | $1,114,743,663 (16.40%) |
Average Equity | $1,245,068,500 (133.12%) | $534,081,250 (25.29%) | $426,279,000 (28.50%) | $331,725,750 (49.81%) |
Average Assets | $1,375,891,250 (126.81%) | $606,619,500 (26.96%) | $477,818,750 (31.02%) | $364,693,000 (29.32%) |
Invested Capital Average | $885,273,000 (108.38%) | $424,836,500 (62.14%) | $262,012,750 (1241.01%) | $19,538,500 (472.46%) |
Shares | 119,309,317 (61.01%) | 74,101,254 (36.06%) | 54,462,518 (16.13%) | 46,897,083 (24.97%) |
